Iniciativa Europeia Medicamentos Inovadores (IMI-2) | pré-publicação de tópicos

 

A Iniciativa Europeia Medicamentos Inovadores (IMI-2) acaba de publicar a lista de tópicos que poderão ser financiados em futuros concursos em diferentes áreas, entre as quais:

• Assessment of the uniqueness of diabetic cardiomyopathy relative to other forms of heart failure using unbiased pheno-mapping approaches
• Genome-environment interactions in inflammatory skin disease
• The value of diagnostics to combat antimicrobial resistance by optimising antibiotic use
• Mitochondrial dysfunction in neurodegeneration
• Support and coordination action for the projects of the neurodegeneration area of the innovative medicines initiative
• A sustainable European induced pluripotent stem cell platform
• Linking digital assessment of mobility to clinical endpoints to drive regulatory acceptance and clinical practice
• Human tumour microenvironment immunoprofiling
• CONCEPTION – continuum of evidence from pregnancy exposures, reproductive toxicology and breastfeeding to improve outcomes now
• Improving the preclinical prediction of adverse effects of pharmaceuticals on the nervous system
• Translational safety biomarker pipeline (TRANSBIOLINE): enabling development and implementation of novel safety biomarkers in clinical trials and diagnosis of disease
• Federated and privacy-preserving machine learning in support of drug discovery
• Pilot programme on a clinical compound bank for repurposing – this programme includes the following topics:
  • Cardiovascular diseases and diabetes
  • Respiratory diseases
  • Neurodegenerative diseases
  • Rare/orphan diseases

Alertamos que esta informação ainda é preliminar e poderá sofrer alterações até à publicação oficial dos concursos. Consulte este link para obter mais detalhes sobre os futuros concursos da IMI-2.

Recordamos ainda que estão abertos os concursos 11 e 12 da IMI-2 até  24.10.2017.

Publicado em 28.09.2017